Home  |  Publications  |  Conferences   |  Join  |  Contact
                           
 
ISSN: 2329-6917

Journal of Leukemia

Open Access
 
 
OMICS International organises 1000+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes
700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
 
 
 
 
 
 
 

Editor-in-Chief

Editor in Chief
Editor-in-Chief 
Professor 
Department of Hematology 
Medical University of Lodz 
Poland
Tel: +48 42 689-51-91
Read Interview session with Tadeusz Robak

Submit Manuscript


Submit manuscript at www.editorialmanager.com/biomedicaljournals/ or send as an e-mail attachment to the Editorial Office at editor.jlu@omicsonline.org
 

About the Journal

Journal of Leukemia (JLU) is a peer reviewed medical journal that includes a wide range of fields in Leukemia, Multiple Myeloma, Acute Lymphoblastic Leukemia, Acute Myleoid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myleloid Leukemia, Hairy Cell Leukemia, Pediatric Leukemia, Leukemia drugs, Stem Cell Transplant, Plasma cell Leukemia, Mast cell Leukemia, Lymphoma Cancer, Lymphoma Symptoms, Spleen cancer, Acute Myelomonocytic Leukemia, Aleukemic Leukemia , Lymphosarcoma, Megakaryocytic Leukemia, Feline Leukemia complex, Epidemiologic studies and other Hematologic malignancies and creates a platform for the authors to make their contribution towards the journal and the editorial office promises peer process for the submitted manuscripts to ensure quality.

Leukemia is one of the best open access journals that aims to publish the most complete and reliable source of information on discoveries and current developments in the mode of Original articles, Review articles, Case reports, Short communications, etc. in the field and provides free online access to the researchers worldwide.

This scholarly open access journal is using Editorial Manager System for online manuscript submission, review and the progress of the article. Editorial board members of Journal of Leukemia or outside experts review manuscripts; at least two independent reviewer’s approval followed by the ditor is required for the acceptance of any citable manuscript.

Submit manuscript at http://www.editorialmanager.com/biomedicaljournals/ or send as an e-mail attachment to the Editorial Office at editor.jlu@omicsonline.org

Leukemia

Leukemia is malignancy of the white platelets. White platelets help your body battle disease. Your platelets shape in your bone marrow. In leukemia, the bone marrow produces anomalous white platelets. These cells group out the sound platelets, making it hard for blood to do its work. Leukemia may influence red platelets, white platelets, and platelets.

Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia is a disease of the blood and bone marrow in which the bone marrow makes an excess of juvenile lymphocytes (a kind of white platelet). Acute lymphocytic leukemia is the most widely recognized sort of growth in kids.

Acute Myleoid Leukemia

AML, also called acute myelogenous leukemia involves the rapid growth of myeloid cells. It occurs in both adults and children and affects about 18,000 people each year in the U.S.

Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia (CLL) is a slow-growing cancer of lymphoid cells that usually affects people over 55 years of age. It is estimated to affect about 16,000 people in the U.S. every year. It almost never occurs in children or adolescents.

Chronic Myleloid Lekumia

Chronic Myleloid Leukemia also known as chronic myelogenous leukemia primarily affects adults and occurs in about 6,000 people every year in the U.S.

Hairy Cell Leukemia

Hairy cell Leukemia (HCL) is an unusual and a rare, slow-growing cancer of the blood. It affects B cells, a type of white blood cell (lymphocyte).

Pediatric Leukemia

Leukemia is the most commonly diagnosed cancer in children, accounting for about 30% of all cases. The incidence peaks at age 3 years in boys and at 2 years in girls. Approximately 1 in 2,000 children will develop it before the age of 15 years.

Leukemia Drugs

Chemotherapy is the standard treatment for many types of leukemia. Even when a cure isn't possible, chemotherapy may help you live longer and feel better.

Stem Cell Transplant

A stem cell transplant (sometimes called a bone marrow transplant) is a medical procedure in which diseased bone marrow is replaced by highly specialized stem cells that develop into healthy bone marrow.

Plasma Cell Leukemia

Plasma cell Leukemia (PCL) is a rare variant of multiple myeloma which is associated with a poor prognosis, with a shorter survival than that of patients presenting with typical multiple myeloma.

Mast Cell Leukemia

Mast cell Leukemia is form marked by overwhelming numbers of tissue mast cells in the peripheral blood.

Lymphoma Cancer

Lymphoma or lymphatic cancer is thus the term given to the group of cancers in the lymphatic system, occurring when some of the white immune cells, called lymphocytes, become abnormal and malignant.

Lymphoma Symptoms

The most common symptom of lymphoma is a painless swelling in a lymph node, usually in the armpit, groin or neck. This is caused by the damaged lymphocytes collecting in that node. The swelling may also ache.

Spleen Cancer

The spleen is a lymphatic organ and has numerous functions in the body including filtering the blood and producing immune cells such as white blood cells. There are a number of different types of spleen cancers including lymphoma, non-Hodgkin's lymphoma and some types of T-cell lymphomas. Roughly 70,000 new cases of lymphoma are diagnosed each year in the US.

Acute Myelomonocytic Leukemia

Acute Myelomonocytic Leukemia one of the more common types of acute myelogenous leukemia, characterized by both malignant monocytes and myeloblasts; it usually affects middle aged to older adults.

Aleukemic Leukemia

Aleukemic Leukemia is a leukemia in which the leukocyte count is normal or below normal; it may be lymphocytic, monocytic, or myelocytic.

Megakaryocytic Leukemia

It is a form with numerous megakaryocytes in the spleen, bone marrow, and other tissues, but decreased numbers or abnormal thrombocytes in the peripheral blood, and anemia. Reported in dogs and cats. Called also megakaryocytic myelosis.

Feline Leukemia Complex

Feline Leukemia is the array of diseases associated with infection of cats by the feline leukemia virus; includes lymphoreticular neoplasms, myelodysplastic disorders and abnormalities of the immune system.

Lymphosarcoma

Lymphosarcoma is a malignant tumor in lymphatic tissue, caused by the growth of abnormal lymphocytes. It is a malignant disease of the lymphoid tissues characterized by proliferation of atypical lymphocytes and their localization in various parts of the body. The jaws may be the sites of lymphosarcomas.


OMICS Group International through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS Group hosts over 700 leading-edge peer reviewed Open Access Journals and organizes over 1000 International Conferences annually all over the world. OMICS Publishing Group journals have over 10 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 50000 eminent personalities that ensure a rapid, quality and quick review process. OMICS Group signed an agreement with more than 1000 International Societies to make healthcare information Open Access. OMICS Group Conferences make the perfect platform for global networking as it brings together renowned speakers and scientists across the globe to a most exciting and memorable scientific event filled with much enlightening interactive sessions, world class exhibitions and poster presentations.

Journal of Leukemia is supporting the 5th World Conference on Cancer Therapy during september 28-30, 2015 Atlanta, USA with the theme of Exploring the Possibilities towards cancer treatment.

 

Recently published articles

 
G2/M Arrest Sensitises Erythroid Leukemia Cells to TRAIL-induced Apoptosis

Séverine Cruet-Hennequart, Tanja Paavilainen, Michael O’Dwyer, Réka Tóth, Michael P Carty, Afshin Samali and Eva Szegezdi

 
Occurrence of Non-Hodgkin Lymphoma after the Diagnosis of Persistent Polyclonal B-cell Lymphocytosis

Jean-Baptiste Méar, Xavier Troussard, Véronique Salaün, Hossein Mossafa, Gandhi Damaj, Cécile Le Naourès, Françoise Galateau-Sallé and Edouard Cornet

 
Application of Sensitive AlleleSEQR Chimerism PCR from Peripheral Blood in Allografted AML/MDS Patients Treated with Pre-emptive Posttransplant Immunomodulation
Urpu Salmenniemi, Veli Kairisto, Jussi Leino, Mervi Putkonen, Marjut Kauppila, Tommi Salmi, Markku Oksman, Kari Remes and Maija Itälä-Remes
 
 
Lenalidomide Polarizes Th1-specific Anti-tumor Immune Response and Expands XBP1 Antigen-Specific Central Memory CD3+CD8+ T cells against Various Solid Tumors
Jooeun Bae, Derin B Keskin, Kristen Cowens, Ann-Hwee Lee, Glen Dranoff, Nikhil C Munshi and Kenneth C Anderson
 
 
 
OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2015-16
 
Meet Inspiring Speakers and Experts at our 1000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@openaccessjournals.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@openaccessjournals.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@openaccessjournals.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@openaccessjournals.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

agrifoodaquavet@openaccessjournals.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@openaccessjournals.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@openaccessjournals.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@openaccessjournals.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@openaccessjournals.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@openaccessjournals.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@openaccessjournals.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@openaccessjournals.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@openaccessjournals.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@openaccessjournals.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@openaccessjournals.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@openaccessjournals.com

1-702-714-7001 Extn: 9042

 
© 2008-2015 OMICS Group - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version